InvestorsHub Logo
Followers 0
Posts 8
Boards Moderated 0
Alias Born 03/12/2009

Re: None

Monday, 01/25/2010 1:45:37 PM

Monday, January 25, 2010 1:45:37 PM

Post# of 19
CEO Markison informed investors at the JPMorgan Health Conference that the company remained on schedule with FDA timelines for two other promising tamper-resistant pain killer drugs. Nonetheless, the road to approvable action letters is littered with potholes:

http://industry.bnet.com/pharma/10006162/king-pharmaceuticals-faces-setbacks-with-abuse-resistant-pain-medicines/